Stemline Therapeutics, Inc. (STML)

Oncology Corporate Profile

Stock Performance

5.5000
0.1700

HQ Location

750 Lexington Avenue, 11th Floor
New York, NY 10022

Company Description

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel oncology therapeutics that target both cancer stem cells (CSCs) and tumor bulk in a variety of cancer types. Stemline is currently developing two clinical-stage product candidates, SL-401 and SL-701.

Website: http://www.stemline.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
SL-401interleukin-3 receptor (IL-3R)Acute Myelogenous Leukemia (AML)II
SL-701 (+ immunostimulant and bevacizumab)immunotherapyGlioblastoma Multiforme (GBM)I
SL-801XPO1 inhibitorVarious cancer typesI

Source: http://www.stemline.com

Recent News Headlines

5/26/2017 12:19 am

5/26/2017 12:19 am

5/26/2017 12:19 am

5/26/2017 12:19 am

5/26/2017 12:19 am

5/18/2017 06:19 am

5/18/2017 06:19 am

5/18/2017 06:19 am

5/18/2017 06:19 am

5/18/2017 06:19 am

5/16/2017 06:19 am

5/16/2017 06:19 am

5/16/2017 06:19 am

5/16/2017 06:19 am

5/16/2017 06:19 am

5/10/2017 12:19 pm

5/2/2017 06:19 pm

5/1/2017 12:19 am

DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Stemline Therapeutics, Inc. and Reminds Investors with Losses to Contact the Firm

4/3/2017 02:05 pm

[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / April 3, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Stemline Therapeutics, Inc. ("Stemline" or the "Company") ...

FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Stemline Therapeutics, Inc. (STML) and Lead Plaintiff Deadline: April 4, 2017

4/3/2017 02:04 pm

[Accesswire] - NEW YORK, NY / ACCESSWIRE / April 3, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Stemline Therapeutics, Inc. ("Stemline" or ...

DEADLINE TOMORROW: Levi & Korsinsky, LLP Reminds Shareholders it Filed a Complaint to Recover Losses Suffered by Investors in Stemline Therapeutics, Inc. - Lead Plaintiff Deadline of April 4, 2017 - STML

4/3/2017 02:03 pm

[Accesswire] - NEW YORK, NY / ACCESSWIRE / April 3, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Stemline Therapeutics, ...

STEMLINE 96 HOUR DEADLINE ALERT: APPROXIMATELY 96 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Stemline Therapeutics, Inc. – (STML)

4/1/2017 02:05 am

[GlobeNewswire] - NEW ORLEANS, March 31, 2017-- Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only ...

UPCOMING DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Stemline Therapeutics, Inc. and Reminds Investors with Losses to Contact the Firm

3/31/2017 04:01 pm

[GlobeNewswire] - IRVINE, Calif., March 31, 2017-- Khang & Khang LLP announces a class action lawsuit against Stemline Therapeutics, Inc.. Investors who purchased shares of the Company either pursuant and/or traceable to ...

STML UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Stemline Therapeutics, Inc. and a Lead Plaintiff Deadline of April 4, 2017

3/31/2017 03:02 pm

[GlobeNewswire] - NEW YORK, March 31, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased ...

DEADLINE TUESDAY: Lundin Law PC Announces Securities Class Action Lawsuit against Stemline Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

3/31/2017 03:00 pm

[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / March 31, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Stemline Therapeutics, Inc. ("Stemline" or the "Company") ...